Dismantling Parkinson’s disease with herbs: MAO-B inhibitory activity and quantification of chemical constituents using HPLC-MS/MS of Egyptian local market plants

References

• Abdel-Mageed WM, Bayoumi S, Salama AAR, Salem-Bekhit MM, Abd-Alrahman SH, Sayed HM. 2014. Antioxidant lipoxygenase inhibitors from the leaf extracts of Simmondsia chinensis. Asian Pac J Trop Med. 7(S1):S521–S526.
   PubMedGoogle Scholar
• Abdel-Mageed WM, Bayoumi SA, Radwan AA, Salem-Bekhit MM, Abd-Alrahman SH, Basudan OA, Sayed HM. 2014. Simmondsia chinensis: a rich source of bioactive flavonoids and lignans. Ind Crops Prod. 60:99–103.
   Web of Science ®Google Scholar
• Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, Hoda MN, Islam F. 2005. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol. 24(3):137–147.
   PubMed Web of Science ®Google Scholar
• Alexander GE. 2004. Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci. 6(3):259–280.
   PubMedGoogle Scholar
• Dhiman P, Malik N, Sobarzo-Sánchez E, Uriarte E, Khatkar A. 2019. Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: targeting neurological and mental disorders. Molecules. 24(3):418.
   Web of Science ®Google Scholar
• Gong W, Zhou Y, Li X, Gao X, Tian J, Qin X, Du G. 2016. Neuroprotective and cytotoxic phthalides from Angelica sinensis radix. Molecules. 21(5):549.
   Web of Science ®Google Scholar
• Hathout RM, El-Ahmady SH, Metwally AA. 2018. Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio/chemo-informatics case study. Nat Prod Res. 32(24):2873–2881.
   PubMed Web of Science ®Google Scholar
• Hwang CK, Chun HS. 2012. Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons. Biosci Biotechnol Biochem. 76(3):536–543.
   PubMed Web of Science ®Google Scholar
• Jeong GS, Kang MG, Lee JY, Lee SR, Park D, Cho M, Kim H. 2020. Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated from Glycyrrhiza uralensis. Molecules. 25(17):3896.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lim SS, Park IS, Lim JS, Seo JY, Kim JS. 2012. Neuroprotective effects of dehydroglyasperin C through activation of heme oxygenase-1 in mouse hippocampal cells. J Agric Food Chem. 60(22):5583–5589.
   PubMed Web of Science ®Google Scholar
• Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K. 2002. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport. 13(14):1715–1720.
   PubMed Web of Science ®Google Scholar
• Li J, Long X, Hu J, Bi J, Zhou T, Guo X, Han C, Huang J, Wang T, Xiong N, et al. 2019. Multiple pathways for natural product treatment of Parkinson's disease: a mini review. Phytomedicine. 60:152954.
   PubMed Web of Science ®Google Scholar
• Lin RD, Hou WC, Yen KY, Lee MH. 2003. Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines. Phytomedicine. 10(8):650–656.
   PubMed Web of Science ®Google Scholar
• Liu L, Chen Y, Zeng RF, Liu Y, Xie SS, Lan JS, Ding Y, Yang YT, Yang J, Zhang T. 2021. Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease. Bioorg Chem. 109:104685.
   PubMed Web of Science ®Google Scholar
• Manoharan S, Vishnupriya V, Gayathri R. 2016. Phytochemical analysis and in vitro antioxidant activity of jojoba oil. J Pharm Sci Res. 8(6):512.
   Google Scholar
• Ravanfar P, Namazi G, Borhani-Haghighi A, Zafarmand S. 2018. Neurologic effects of licorice: a review. Pharmacogn Rev. 12(23):115.
   Google Scholar
• Ravi SK, Narasingappa RB, Joshi CG, Girish TK, Vincent B. 2018. Neuroprotective effects of Cassia tora against paraquat-induced neurodegeneration: relevance for Parkinson's disease. Nat Prod Res. 32(12):1476–1480.
   PubMed Web of Science ®Google Scholar
• Ribaudo G, Zanforlin E, Canton M, Bova S, Zagotto G. 2018. Preliminary studies of berberine and its semi-synthetic derivatives as a promising class of multi-target anti-Parkinson agents. Nat Prod Res. 32(12):1395–1401.
   PubMed Web of Science ®Google Scholar
• Saboo S, Tapadiya R, Khadabadi S, Deokate UA. 2010. In vitro antioxidant activity and total phenolic, flavonoid contents of the crude extracts of Pterospermumacerifolium Wild leaves (Sterculiaceae).. Journal of Pharmacy Research. 3:417–23.
   Google Scholar
• Sankar SR, Manivasagam T, Krishnamurti A, Ramanathan M. 2007. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol Biol Lett. 12(4):473–481.
   PubMed Web of Science ®Google Scholar
• Saura J, Andrés N, Andrade C, Ojuel J, Eriksson K, Mahy N. 1997. Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging. 18(5):497–507.
   PubMed Web of Science ®Google Scholar
• Vegh C, Wear D, Okaj I, Huggard R, Culmone L, Eren S, Cohen J, Rishi AK, Pandey S. 2021. Combined ubisol-Q10 and Ashwagandha root extract target multiple biochemical mechanisms and reduces neurodegeneration in a paraquat-induced rat model of Parkinson's disease. Antioxidants (Basel). 10(4):563.
   PubMedGoogle Scholar
• Venditti A, Bianco A. 2020. Sulfur-containing secondary metabolites as neuroprotective agents. Curr Med Chem. 27(26):4421–4436.
   PubMed Web of Science ®Google Scholar
• Zhao J, Nakamura N, Hattori M, Kuboyama T, Tohda C, Komatsu K. 2002. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem Pharm Bull (Tokyo). 50(6):760–765.
   PubMed Web of Science ®Google Scholar